Impact of B-cell count and imaging screening in cMBL: Any need to revise the current guidelines

Leukemia

Volumn 26, Issue 7, 2012, Pages 1703-1707

  Scarfo L ^a,b   Zibellini, S ^c   Tedeschi, A ^d   Maura, F ^e   Neri, A ^e   Bertazzoni, P ^f   Sarina, B ^g   Nalli, G ^h   Motta, M ⁱ   Rossini, F ^j   Cortelezzi, A ^e   Montillo, M ^d   Orlandi, E ^c   Ghia, P ^a,k  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d OSPEDALE NIGUARDA CA GRANDA   (Italy)

^e FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^f EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^g HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^h Presidio Ospedaliero di Lodi ^*  (Italy)

ⁱ SPEDALI CIVILI   (Italy)

^j SAN GERARDO HOSPITAL   (Italy)

^k VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN;

ADULT; AGED; B LYMPHOCYTE; B LYMPHOCYTE COUNT; CANCER STAGING; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; CLINICAL MONOCLONAL B CELL LYMPHOCYTOSIS; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; HUMAN; IMMUNOGLOBULIN HEAVY CHAIN GENE; IMMUNOGLOBULIN HEAVY CHAIN VARIABLE GENE; ITALY; LETTER; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONOCLONAL B CELL LYMPHOCYTOSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL;

AGED; B-LYMPHOCYTES; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOCYTOSIS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; SURVIVAL RATE;

EID: 84860900458     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2012.20     Document Type: Letter

References (15)

1. Molica S, Levato D. What is changing in the natural history of chronic lymphocytic leukemia? Haematologica 2001; 86: 8-12.
2. Marti GE, Rawstron AC, Ghia P, Hillmen P, Houlston RS, Kay N et al. Diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol 2005; 130: 325-332.
3. Shanafelt TD, Ghia P, Lanasa MC, Landgren O, Rawstron AC. Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management. Leukemia 2010; 24: 512-520.
4. Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Döhner H et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the international workshop on chronic lymphocytic leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 2008; 111: 5446-5456.
5. Scarfo L, Dagklis A, Scielzo C, Fazi C, Ghia P. CLL-like monoclonal B-cell lymphocytosis: are we all bound to have it? Semin Cancer Biol 2010; 20: 384-390.
6. Dagklis A, Fazi C, Sala C, Cantarelli V, Scielzo C, Massacane R et al. The immunoglobulin gene repertoire of low-count chronic lymphocytic leukemia (CLL)-like monoclonal B lymphocytosis is different from CLL: diagnostic implications for clinical monitoring. Blood 2009; 114: 26-32.
7. Rawstron AC, Bennett FL, O0Connor SJ, Kwok M, Fenton JA, Plummer M et al. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med 2008; 359: 575-583.
8. Rawstron AC, Shanafelt T, Lanasa MC, Landgren O, Hanson C, Orfao A et al. Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL). Cytometry B Clin Cytom 2010; 78 (Suppl 1): S19-S23.
9. Shanafelt TD, Kay NE, Jenkins G, Call TG, Zent CS, Jelinek DF et al. B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome. Blood 2009; 113: 4188-4196.
10. Shanafelt TD, Kay NE, Rabe KG, Call TG, Zent CS, Maddocks K et al. Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia. J Clin Oncol 2009; 27: 3959-3963.
11. Rossi D, Sozzi E, Puma A, De Paoli L, Rasi S, Spina V et al. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors. Br J Haematol 2009; 146: 64-75.
12. Molica S, Mauro FR, Giannarelli D, Lauria F, Cortelezzi A, Brugiatelli M et al. Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working group. Haematologica 2010; 96: 277-283.
13. Faguet GB, Agee JF, Marti GE. CD5 and cCLLa expression in chronic lymphocytic leukemia (CLL): demonstration of their relative prevalence and that of other common B-CLL markers. Leuk Lymphoma 1992; 6: 335-344.
14. Shanafelt TD, Kay NE, Rabe KG, Call TG, Zent CS, Schwager SM et al. Survival of patients with clinically identified monoclonal B-cell lymphocytosis (MBL) relative to the age-and sex-matched general population. Leukemia 2012; 26: 373-376.
15. Gibson SE, Swerdlow SH, Ferry JA, Surti U, Dal Cin P, Harris HL et al. Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis. Haematologica 2011; 96: 1144-1152.